We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Oct 19
The transaction is expected to close in the first half of 2020, subject to the approval of Achillion…
Healx has raised $56m in Series B funding to aid its AI-powered drug discovery mission. NS Healthcare caught…
15 Oct 19
Roche’s MabThera/Rituxan has secured the FDA approval in June 2018 and the European Commission approval in March 2019
14 Oct 19
JADE MONO-1 is a 12-week, double-blind, randomised parallel group study to evaluate abrocitinib 200mg, abrocitinib 100mg, or placebo
14 Oct 19
The US FDA approval of REYVOW represents the first new class of acute migraine treatment approved in more…
11 Oct 19
The FINCH Phase III programme has been designed to investigate the efficacy and safety of filgotinib, in early-stage…
Exscientia has set out its ambition to become the "most creative and productive" drug discovery organisation in the…
10 Oct 19
The lebrikizumab Phase 3 study programme is designed to confirm the safety and efficacy of lebrikizumab in treating…
10 Oct 19
In 2015, a jury found that J&J has failed to warn of the risk of gynecomastia, and awarded…
09 Oct 19
Gilead Sciences has filed the NDA for filgotinib based on the data from the Phase 3 FINCH clinical…